Cargando…
P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430719/ http://dx.doi.org/10.1097/01.HS9.0000848576.67323.0a |
| _version_ | 1784779852564398080 |
|---|---|
| author | Garcia-Vicente, R. Rodriguez-Garcia, A. Gomez-Gordo, R. Ortega-Hernandez, A. Ancos, R. Serrano, S. Modrego, J. Leivas, A. Valeri, A. Jimenez-Ubieto, A. Sanchez-Pina, J. M. Paciello, M. L. Gomez-Garre, D. Martinez-Lopez, J. Linares, M. |
| author_facet | Garcia-Vicente, R. Rodriguez-Garcia, A. Gomez-Gordo, R. Ortega-Hernandez, A. Ancos, R. Serrano, S. Modrego, J. Leivas, A. Valeri, A. Jimenez-Ubieto, A. Sanchez-Pina, J. M. Paciello, M. L. Gomez-Garre, D. Martinez-Lopez, J. Linares, M. |
| author_sort | Garcia-Vicente, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430719 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307192022-08-31 P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY Garcia-Vicente, R. Rodriguez-Garcia, A. Gomez-Gordo, R. Ortega-Hernandez, A. Ancos, R. Serrano, S. Modrego, J. Leivas, A. Valeri, A. Jimenez-Ubieto, A. Sanchez-Pina, J. M. Paciello, M. L. Gomez-Garre, D. Martinez-Lopez, J. Linares, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430719/ http://dx.doi.org/10.1097/01.HS9.0000848576.67323.0a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Garcia-Vicente, R. Rodriguez-Garcia, A. Gomez-Gordo, R. Ortega-Hernandez, A. Ancos, R. Serrano, S. Modrego, J. Leivas, A. Valeri, A. Jimenez-Ubieto, A. Sanchez-Pina, J. M. Paciello, M. L. Gomez-Garre, D. Martinez-Lopez, J. Linares, M. P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY |
| title | P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY |
| title_full | P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY |
| title_fullStr | P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY |
| title_full_unstemmed | P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY |
| title_short | P1430: GUT MICROBIOTA DIVERSITY AND BUTYRATE PRODUCERS IMPACTS ON NON-HODGKIN LYMPHOMA PATIENTS RESPONSE TO CD19 CAR-T THERAPY |
| title_sort | p1430: gut microbiota diversity and butyrate producers impacts on non-hodgkin lymphoma patients response to cd19 car-t therapy |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430719/ http://dx.doi.org/10.1097/01.HS9.0000848576.67323.0a |
| work_keys_str_mv | AT garciavicenter p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT rodriguezgarciaa p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT gomezgordor p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT ortegahernandeza p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT ancosr p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT serranos p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT modregoj p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT leivasa p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT valeria p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT jimenezubietoa p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT sanchezpinajm p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT pacielloml p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT gomezgarred p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT martinezlopezj p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy AT linaresm p1430gutmicrobiotadiversityandbutyrateproducersimpactsonnonhodgkinlymphomapatientsresponsetocd19carttherapy |